These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 31944351)
21. Parenteral anticoagulation in ambulatory patients with cancer. Akl EA; Kahale LA; Ballout RA; Barba M; Yosuico VE; van Doormaal FF; Middeldorp S; Bryant A; Schünemann H Cochrane Database Syst Rev; 2014 Dec; (12):CD006652. PubMed ID: 25491949 [TBL] [Abstract][Full Text] [Related]
22. Oral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Akl EA; Kahale L; Terrenato I; Neumann I; Yosuico VE; Barba M; Sperati F; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD006466. PubMed ID: 24897382 [TBL] [Abstract][Full Text] [Related]
23. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Douketis JD; Johnson JA; Turpie AG Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166 [TBL] [Abstract][Full Text] [Related]
24. Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings. Nikolakopoulos I; Spyropoulos AC Semin Thromb Hemost; 2020 Feb; 46(1):26-31. PubMed ID: 31830765 [TBL] [Abstract][Full Text] [Related]
26. Anticoagulation for patients with cancer and central venous catheters. Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H Cochrane Database Syst Rev; 2011 Apr; (4):CD006468. PubMed ID: 21491394 [TBL] [Abstract][Full Text] [Related]
27. Anticoagulation for patients with cancer and central venous catheters. Akl EA; Vasireddi SR; Gunukula S; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H Cochrane Database Syst Rev; 2011 Feb; (2):CD006468. PubMed ID: 21328283 [TBL] [Abstract][Full Text] [Related]
28. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer. Kirkilesis GI; Kakkos SK; Tsolakis IA Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186 [TBL] [Abstract][Full Text] [Related]
29. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H Cochrane Database Syst Rev; 2011 Apr; (4):CD006652. PubMed ID: 21491396 [TBL] [Abstract][Full Text] [Related]
30. Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation. Akl EA; Gunukula S; Barba M; Yosuico VE; van Doormaal FF; Kuipers S; Middeldorp S; Dickinson HO; Bryant A; Schünemann H Cochrane Database Syst Rev; 2011 Jan; (1):CD006652. PubMed ID: 21249680 [TBL] [Abstract][Full Text] [Related]
32. Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation--a study in 200 patients. Hammerstingl C; Omran H Europace; 2011 Sep; 13(9):1304-10. PubMed ID: 21508005 [TBL] [Abstract][Full Text] [Related]
33. Management of Antithrombotic Agents During Surgery or Other Kinds of Medical Procedures With Bleeding: The MARK Study. Gotoh S; Yasaka M; Nakamura A; Kuwashiro T; Okada Y J Am Heart Assoc; 2020 Mar; 9(5):e012774. PubMed ID: 32079478 [TBL] [Abstract][Full Text] [Related]
34. Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy. Spyropoulos AC; Bauersachs RM; Omran H; Cohen M Curr Med Res Opin; 2006 Jun; 22(6):1109-22. PubMed ID: 16846544 [TBL] [Abstract][Full Text] [Related]
35. Risk of thromboembolism with short-term interruption of warfarin therapy. Garcia DA; Regan S; Henault LE; Upadhyay A; Baker J; Othman M; Hylek EM Arch Intern Med; 2008 Jan; 168(1):63-9. PubMed ID: 18195197 [TBL] [Abstract][Full Text] [Related]
36. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy. Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709 [TBL] [Abstract][Full Text] [Related]
37. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845 [TBL] [Abstract][Full Text] [Related]
38. Heparin-bridging therapy is associated with post-colorectal polypectomy bleeding in patients whose oral anticoagulation therapy is interrupted. Sakai T; Nagami Y; Shiba M; Hayashi K; Kinoshita Y; Maruyama H; Kato K; Minamino H; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Taira K; Kamata N; Yamagami H; Tanigawa T; Watanabe T; Fujiwara Y Scand J Gastroenterol; 2018; 53(10-11):1304-1310. PubMed ID: 30345853 [TBL] [Abstract][Full Text] [Related]
39. Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Spyropoulos AC; Turpie AG Curr Opin Pulm Med; 2005 Sep; 11(5):373-9. PubMed ID: 16093808 [TBL] [Abstract][Full Text] [Related]